Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -3,237 | -4,721 | N/A | N/A |
| Depreciation Amortization | 97 | 143 | N/A | N/A |
| Accounts payable and accrued liabilities | -233 | 122 | N/A | N/A |
| Other Working Capital | -756 | -75 | N/A | N/A |
| Other Operating Activity | 99 | 609 | 0 | 0 |
| Operating Cash Flow | $-4,029 | $-3,922 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 3,109 | 150 | N/A | N/A |
| Debt Repayment | -810 | -764 | N/A | N/A |
| Other Financing Activity | 269 | 5,348 | 0 | 0 |
| Financing Cash Flow | $2,567 | $4,735 | $N/A | $N/A |
| Beginning Cash Position | 1,992 | 1,180 | N/A | N/A |
| End Cash Position | 530 | 1,992 | N/A | N/A |
| Net Cash Flow | $-1,461 | $812 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,029 | -3,922 | N/A | N/A |
| Free Cash Flow | -4,029 | -3,922 | 0 | 0 |